Additional reduction of residual symptoms with aripiprazole augmentation in the patients with partially remitted major depressive disorder
Cheolmin Shin 1, Chi-Un Pae 2, 7, Kyung Phil Kwak 3, Sang Won Jeon 4, Hyun-Ghang Jeong 1, Jong-Woo Kim 5, Youn Jung Lee 6, Ashwin A. Patkar 7, Changsu Han 1*
1Department of Psychiatry, Korea University College of Medicine, Seoul, Republic of Korea, 2Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, 3Department of Psychiatry, Dongguk University Gyeongju Hospital, Gyeongju, Republic of Korea, 4Department of Psychiatry, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Republic of Korea, 5Department of Psychiatry, Kyung Hee University School of Medicine, Seoul, Republic of Korea., 6Department of Psychiatry, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Republic of Korea, 7Department of Psychiatry and Behavioural Sciences, Duke University Medical Center, Durham, North Carolina, USA